ICC Melanoma 2020
10+
Downloads
Everyone
info
About this app
HOW TO MANAGE TOXICITY AND ASSESS THE ANSWER TO IMMUNOTHERAPY IN MELANOMA PATIENTS
The immunological therapy of melanoma is going through a phase of great evolution, thanks to the important results obtained in many clinical studies, starting from 2010, following the introduction of antibodies against immunological checkpoints such as CTLA-4 and, in particular, PD -1. The purpose of this project is to investigate the main scenarios of difficult management of melanoma patients treated with ant-PD-1 antibodies, through examples of interactive clinical situations.
The immunological therapy of melanoma is going through a phase of great evolution, thanks to the important results obtained in many clinical studies, starting from 2010, following the introduction of antibodies against immunological checkpoints such as CTLA-4 and, in particular, PD -1. The purpose of this project is to investigate the main scenarios of difficult management of melanoma patients treated with ant-PD-1 antibodies, through examples of interactive clinical situations.
Updated on
Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.
No data shared with third parties
Learn more about how developers declare sharing
No data collected
Learn more about how developers declare collection
What's new
Aggiornamento riferimenti per corso FAD 2020
